These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S. Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673 [Abstract] [Full Text] [Related]
3. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats]. Niwa T, Yazawa T, Maeda K, Ise M, Sugano M, Kodama T, Uehara Y. Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492 [Abstract] [Full Text] [Related]
5. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Niwa T, Tsukushi S, Ise M, Miyazaki T, Tsubakihara Y, Owada A, Shiigai T. Miner Electrolyte Metab; 1997 Jun; 23(3-6):179-84. PubMed ID: 9387112 [Abstract] [Full Text] [Related]
6. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. Sanaka T, Fujimoto K, Niwayama J, Nishimura H, Naito T, Higuchi C, Akizawa T, Koide K, Koshikawa S. Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949 [Abstract] [Full Text] [Related]
7. Oral sorbent AST-120 increases renal NO synthesis in uremic rats. Tumur Z, Niwa T. J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446 [Abstract] [Full Text] [Related]
10. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T. Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455 [Abstract] [Full Text] [Related]
11. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure. Komiya T, Miura K, Tsukamoto J, Okamura M, Tamada S, Asai T, Tashiro K, Kuwabara N, Iwao H, Yoshikawa J. Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984 [Abstract] [Full Text] [Related]
12. Uremic toxins and oral adsorbents. Goto S, Yoshiya K, Kita T, Fujii H, Fukagawa M. Ther Apher Dial; 2011 Apr; 15(2):132-4. PubMed ID: 21426503 [Abstract] [Full Text] [Related]
14. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats. Nakagawa N, Hasebe N, Sumitomo K, Fujino T, Fukuzawa J, Hirayama T, Kikuchi K. Am J Nephrol; 2006 Apr; 26(5):455-61. PubMed ID: 17057375 [Abstract] [Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]